… -harm, the side effects of depression medications and the trauma of going …

… late-stage study of its depression drug after an initial run of …

Members demand comes after the HHS Secretary directed the agency to assess the “threat” posed by SSRIs   Vermont Business Magazine Last week, Rep. Becca Balint joined Rep. Andrea Salinas (OR-06) and Senator Tina Smith (D-MN) in leading their colleagues in …

… phase 3 trials of its depression drug REL-1017 after a data …

… episode. Conversely, the effectiveness of depression medications overall had a small short …

It's no secret that in today's world, mental health is a big deal.... And it should be. Did you know that 46% of Americans will meet the criteria for a diagnosable mental health condition sometime in their life? This is according to the Mental …

… as an adjunct to depression drugs they were already taking. … common with currently available depression medications and lead many patients … and the nasal spray depression drug Spravato. The pharma giant … is bringing a depression drug prospect into the fold …

Bengaluru: Johnson & Johnson will stop late-stage studies of its experimental drug to treat major depressive disorder due to a lack of sufficient efficacy, the drug and medical device maker said on Thursday. The company was testing its once-daily drug, …

(Reuters) -Johnson & Johnson said on Thursday it will discontinue a late-stage study of its add-on treatment for major depressive disorder due to insufficient efficacy in the target patient population. The company said it will explore future …

… a side effect of his depression medication, the family was not alarmed …